Free Trial
→ Elon Musk’s $1 Quadrillion AI IPO (From Brownstone Research) (Ad)tc pixel Free RVP Stock Alerts

Retractable Technologies (RVP) Competitors

Retractable Technologies logo
$0.72 +0.07 (+11.38%)
Closing price 03:59 PM Eastern
Extended Trading
$0.72 0.00 (0.00%)
As of 04:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

RVP vs. STSS, LNSR, SRTS, MDAI, and NSPR

Should you be buying Retractable Technologies stock or one of its competitors? The main competitors of Retractable Technologies include Sharps Technology (STSS), LENSAR (LNSR), Sensus Healthcare (SRTS), Spectral AI (MDAI), and InspireMD (NSPR). These companies are all part of the "medical equipment" industry.

How does Retractable Technologies compare to Sharps Technology?

Sharps Technology (NASDAQ:STSS) and Retractable Technologies (NYSE:RVP) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, analyst recommendations, dividends, profitability, valuation, risk and earnings.

17.2% of Sharps Technology shares are held by institutional investors. Comparatively, 7.6% of Retractable Technologies shares are held by institutional investors. 1.2% of Sharps Technology shares are held by company insiders. Comparatively, 59.5% of Retractable Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Sharps Technology has a beta of 2.03, meaning that its share price is 103% more volatile than the S&P 500. Comparatively, Retractable Technologies has a beta of 1.25, meaning that its share price is 25% more volatile than the S&P 500.

In the previous week, Sharps Technology had 1 more articles in the media than Retractable Technologies. MarketBeat recorded 2 mentions for Sharps Technology and 1 mentions for Retractable Technologies. Sharps Technology's average media sentiment score of 0.56 beat Retractable Technologies' score of 0.00 indicating that Sharps Technology is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sharps Technology
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Retractable Technologies
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sharps Technology
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Retractable Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Retractable Technologies has higher revenue and earnings than Sharps Technology. Retractable Technologies is trading at a lower price-to-earnings ratio than Sharps Technology, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sharps Technology$200K367.37-$282.50M-$831.83N/A
Retractable Technologies$38.27M0.57-$7.01M-$0.42N/A

Sharps Technology has a net margin of 0.00% compared to Retractable Technologies' net margin of -41.11%. Retractable Technologies' return on equity of -17.15% beat Sharps Technology's return on equity.

Company Net Margins Return on Equity Return on Assets
Sharps TechnologyN/A -145.56% -140.36%
Retractable Technologies -41.11%-17.15%-9.33%

Summary

Sharps Technology beats Retractable Technologies on 8 of the 14 factors compared between the two stocks.

How does Retractable Technologies compare to LENSAR?

LENSAR (NASDAQ:LNSR) and Retractable Technologies (NYSE:RVP) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, analyst recommendations, dividends, profitability, valuation, risk and earnings.

Retractable Technologies has lower revenue, but higher earnings than LENSAR. LENSAR is trading at a lower price-to-earnings ratio than Retractable Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LENSAR$58.44M1.13-$34.28M-$2.90N/A
Retractable Technologies$38.27M0.57-$7.01M-$0.42N/A

In the previous week, LENSAR had 1 more articles in the media than Retractable Technologies. MarketBeat recorded 2 mentions for LENSAR and 1 mentions for Retractable Technologies. LENSAR's average media sentiment score of 0.00 equaled Retractable Technologies'average media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LENSAR
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Retractable Technologies
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

40.2% of LENSAR shares are held by institutional investors. Comparatively, 7.6% of Retractable Technologies shares are held by institutional investors. 66.0% of LENSAR shares are held by company insiders. Comparatively, 59.5% of Retractable Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

LENSAR currently has a consensus price target of $10.00, suggesting a potential upside of 82.48%. Given LENSAR's stronger consensus rating and higher possible upside, equities research analysts clearly believe LENSAR is more favorable than Retractable Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LENSAR
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
Retractable Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

LENSAR has a beta of 0.84, meaning that its share price is 16% less volatile than the S&P 500. Comparatively, Retractable Technologies has a beta of 1.25, meaning that its share price is 25% more volatile than the S&P 500.

Retractable Technologies has a net margin of -41.11% compared to LENSAR's net margin of -58.66%. LENSAR's return on equity of 0.00% beat Retractable Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
LENSAR-58.66% N/A -48.11%
Retractable Technologies -41.11%-17.15%-9.33%

Summary

LENSAR beats Retractable Technologies on 9 of the 15 factors compared between the two stocks.

How does Retractable Technologies compare to Sensus Healthcare?

Retractable Technologies (NYSE:RVP) and Sensus Healthcare (NASDAQ:SRTS) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, valuation, earnings, analyst recommendations, media sentiment, risk and institutional ownership.

Retractable Technologies has higher revenue and earnings than Sensus Healthcare. Sensus Healthcare is trading at a lower price-to-earnings ratio than Retractable Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Retractable Technologies$38.27M0.57-$7.01M-$0.42N/A
Sensus Healthcare$27.48M2.35-$7.72M-$0.47N/A

In the previous week, Sensus Healthcare had 2 more articles in the media than Retractable Technologies. MarketBeat recorded 3 mentions for Sensus Healthcare and 1 mentions for Retractable Technologies. Sensus Healthcare's average media sentiment score of 0.87 beat Retractable Technologies' score of 0.00 indicating that Sensus Healthcare is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Retractable Technologies
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Sensus Healthcare
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

7.6% of Retractable Technologies shares are owned by institutional investors. Comparatively, 25.3% of Sensus Healthcare shares are owned by institutional investors. 59.5% of Retractable Technologies shares are owned by insiders. Comparatively, 8.9% of Sensus Healthcare shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Sensus Healthcare has a consensus price target of $6.88, indicating a potential upside of 74.94%. Given Sensus Healthcare's stronger consensus rating and higher probable upside, analysts plainly believe Sensus Healthcare is more favorable than Retractable Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Retractable Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Sensus Healthcare
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50

Retractable Technologies has a beta of 1.25, meaning that its stock price is 25% more volatile than the S&P 500. Comparatively, Sensus Healthcare has a beta of 1.19, meaning that its stock price is 19% more volatile than the S&P 500.

Sensus Healthcare has a net margin of -28.09% compared to Retractable Technologies' net margin of -41.11%. Sensus Healthcare's return on equity of -15.11% beat Retractable Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Retractable Technologies-41.11% -17.15% -9.33%
Sensus Healthcare -28.09%-15.11%-13.40%

Summary

Sensus Healthcare beats Retractable Technologies on 9 of the 16 factors compared between the two stocks.

How does Retractable Technologies compare to Spectral AI?

Retractable Technologies (NYSE:RVP) and Spectral AI (NASDAQ:MDAI) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, earnings, media sentiment, risk, institutional ownership, valuation and profitability.

Retractable Technologies has higher revenue and earnings than Spectral AI. Spectral AI is trading at a lower price-to-earnings ratio than Retractable Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Retractable Technologies$38.27M0.57-$7.01M-$0.42N/A
Spectral AI$19.65M3.68-$7.57M-$0.31N/A

In the previous week, Spectral AI had 1 more articles in the media than Retractable Technologies. MarketBeat recorded 2 mentions for Spectral AI and 1 mentions for Retractable Technologies. Retractable Technologies' average media sentiment score of 0.00 equaled Spectral AI'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Retractable Technologies
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Spectral AI
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Retractable Technologies has a beta of 1.25, meaning that its share price is 25% more volatile than the S&P 500. Comparatively, Spectral AI has a beta of 1.16, meaning that its share price is 16% more volatile than the S&P 500.

Spectral AI has a consensus price target of $3.00, indicating a potential upside of 32.16%. Given Spectral AI's stronger consensus rating and higher possible upside, analysts clearly believe Spectral AI is more favorable than Retractable Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Retractable Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Spectral AI
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

7.6% of Retractable Technologies shares are held by institutional investors. Comparatively, 67.1% of Spectral AI shares are held by institutional investors. 59.5% of Retractable Technologies shares are held by insiders. Comparatively, 30.7% of Spectral AI shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Spectral AI's return on equity of 0.00% beat Retractable Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Retractable Technologies-41.11% -17.15% -9.33%
Spectral AI -41.11%N/A -35.64%

Summary

Spectral AI beats Retractable Technologies on 8 of the 14 factors compared between the two stocks.

How does Retractable Technologies compare to InspireMD?

Retractable Technologies (NYSE:RVP) and InspireMD (NYSE:NSPR) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, earnings, media sentiment, risk, institutional ownership, valuation and profitability.

Retractable Technologies has higher revenue and earnings than InspireMD. Retractable Technologies is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Retractable Technologies$38.27M0.57-$7.01M-$0.42N/A
InspireMD$8.98M5.74-$19.92M-$0.79N/A

In the previous week, InspireMD had 10 more articles in the media than Retractable Technologies. MarketBeat recorded 11 mentions for InspireMD and 1 mentions for Retractable Technologies. InspireMD's average media sentiment score of 0.28 beat Retractable Technologies' score of 0.00 indicating that InspireMD is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Retractable Technologies
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
InspireMD
2 Very Positive mention(s)
1 Positive mention(s)
8 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Retractable Technologies has a beta of 1.25, meaning that its share price is 25% more volatile than the S&P 500. Comparatively, InspireMD has a beta of 0.83, meaning that its share price is 17% less volatile than the S&P 500.

InspireMD has a consensus price target of $4.50, indicating a potential upside of 309.09%. Given InspireMD's stronger consensus rating and higher possible upside, analysts clearly believe InspireMD is more favorable than Retractable Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Retractable Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
InspireMD
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

7.6% of Retractable Technologies shares are held by institutional investors. Comparatively, 44.8% of InspireMD shares are held by institutional investors. 59.5% of Retractable Technologies shares are held by insiders. Comparatively, 34.1% of InspireMD shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Retractable Technologies has a net margin of -41.11% compared to InspireMD's net margin of -413.96%. Retractable Technologies' return on equity of -17.15% beat InspireMD's return on equity.

Company Net Margins Return on Equity Return on Assets
Retractable Technologies-41.11% -17.15% -9.33%
InspireMD -413.96%-69.42%-57.68%

Summary

Retractable Technologies beats InspireMD on 9 of the 16 factors compared between the two stocks.

Get Retractable Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for RVP and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RVP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RVP vs. The Competition

Export
MetricRetractable TechnologiesSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market Cap$21.67M$46.11M$6.25B$22.95B
Dividend YieldN/A1.08%2.73%4.03%
P/E Ratio-1.3418.5829.0428.58
Price / Sales0.5730.72476.6123.57
Price / Cash48.2518.8827.6219.03
Price / Book0.2214.279.674.68
Net Income-$7.01M-$20.10M$3.55B$1.07B
7 Day Performance16.06%-1.39%1.70%0.89%
1 Month Performance6.00%-1.61%5.62%6.56%
1 Year Performance-3.72%10.93%34.41%31.66%

Retractable Technologies Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RVP
Retractable Technologies
N/A$0.72
+11.4%		N/AN/A$21.67M$38.27MN/A240
STSS
Sharps Technology
0.452 of 5 stars		$1.74
-3.1%		N/AN/A$67.09M$200KN/A3
LNSR
LENSAR
1.3414 of 5 stars		$5.31
-0.7%		$10.00
+88.3%		N/A$64.23M$58.44MN/A110
SRTS
Sensus Healthcare
2.8258 of 5 stars		$3.90
+0.1%		$6.88
+76.5%		N/A$64.12M$27.48MN/A40
MDAI
Spectral AI
1.4877 of 5 stars		$1.94
-2.3%		$3.00
+55.0%		N/A$61.58M$19.65MN/A83

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NYSE:RVP) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
The Iran War Just Broke the Gold Market
The Iran war isn't just a geopolitical event. It's a financial one. Within hours of the strikes, oil surged...
Behind the Markets | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Elon Unveils AI Passive Income Stream for Millions of Americans
During Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...
InvestorPlace | Sponsoredtc pixel
Invest in SpaceX Before IPO
SpaceX is already one of the most valuable private companies on Earth, and some analysts believe its valuation...
NXT Wave Research | Sponsoredtc pixel
Before you buy SpaceX shares, consider this alternative approach
SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...
Weiss Ratings | Sponsoredtc pixel